|
|
|
Volumn 168, Issue 13, 2003, Pages 1644-1645;-author-reply-1645
|
|
Osteoporosis guidelines.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
CANADA;
COST BENEFIT ANALYSIS;
ECONOMICS;
FEMALE;
HUMAN;
NOTE;
POSTMENOPAUSE OSTEOPOROSIS;
PRACTICE GUIDELINE;
AGED;
CHEMICALLY INDUCED DISORDER;
MIDDLE AGED;
VEIN THROMBOSIS;
CANADA;
COST-BENEFIT ANALYSIS;
FEMALE;
HUMANS;
OSTEOPOROSIS, POSTMENOPAUSAL;
PRACTICE GUIDELINES;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
AGED;
MIDDLE AGED;
VENOUS THROMBOSIS;
|
|
EID: 0038004733
PISSN: 08203946
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
